Idiotype vaccination for lymphoma: moving towards optimisation.
Houot
Roch
R
Oncology Division, Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Levy
Ronald
R
D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology* / Q000627:therapeutic use*; D007167:Immunotherapy; D008223:Lymphoma / Q000276:immunology* / Q000628:therapy*; D014611:Vaccination
D019496:Cancer Vaccines; D007130:Immunoglobulin Idiotypes